Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy

OBJECTIVES: Combination chemotherapy with third-generation, nonplatinum agents (ie, gemcitabine, vinorelbine, taxanes, or camptothecins) represents a well-tolerated frontline treatment option for metastatic non–small-cell lung cancer and might play a role as salvage therapy as well. The aim of this...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Clin Oncol
Autors principals: William, William N., Khuri, Fadlo R., Fossella, Frank V., Glisson, Bonnie S., Zinner, Ralph G., Lee, J. Jack, Herbst, Roy S., Lippman, Scott M., Kim, Edward S.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118944/
https://ncbi.nlm.nih.gov/pubmed/19687727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0b013e318199fb99
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars